Walvax Biotechnology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -4.00% vs -22.38% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 680.71% vs -151.44% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "443.80",
          "val2": "462.30",
          "chgp": "-4.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "129.90",
          "val2": "60.40",
          "chgp": "115.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.10",
          "val2": "0.40",
          "chgp": "1,675.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.10",
          "val2": "14.10",
          "chgp": "-235.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "114.40",
          "val2": "-19.70",
          "chgp": "680.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "292.60%",
          "val2": "-97.50%",
          "chgp": "39.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -14.31% vs -31.28% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -28.21% vs -65.89% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,410.30",
          "val2": "2,812.70",
          "chgp": "-14.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "481.70",
          "val2": "488.40",
          "chgp": "-1.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "8.70",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-48.00",
          "val2": "-98.30",
          "chgp": "51.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "125.20",
          "val2": "174.40",
          "chgp": "-28.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.00%",
          "val2": "27.30%",
          "chgp": "0.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

443.80

462.30

-4.00%

Operating Profit (PBDIT) excl Other Income

129.90

60.40

115.07%

Interest

7.10

0.40

1,675.00%

Exceptional Items

-19.10

14.10

-235.46%

Consolidate Net Profit

114.40

-19.70

680.71%

Operating Profit Margin (Excl OI)

292.60%

-97.50%

39.01%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -4.00% vs -22.38% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 680.71% vs -151.44% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,410.30

2,812.70

-14.31%

Operating Profit (PBDIT) excl Other Income

481.70

488.40

-1.37%

Interest

0.00

8.70

-100.00%

Exceptional Items

-48.00

-98.30

51.17%

Consolidate Net Profit

125.20

174.40

-28.21%

Operating Profit Margin (Excl OI)

29.00%

27.30%

0.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -14.31% vs -31.28% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -28.21% vs -65.89% in Dec 2024

All Annual Results